Cargando…

Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report

INTRODUCTION: There is currently no optimal treatment modality for refractory or relapsed Extranodal NK/T-cell lymphoma, nasal type (ENKTL). In recent years, programmed cell death protein 1 (PD-1)/programmed cell – ligand 1 pathway blockade and histone deacetylase inhibitors have emerged as promisin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jingyan, Xu, Xihui, Chen, Jieyu, Wang, Jing, Jiang, Chong, Lv, Chenglan, Chen, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	4800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969288/ https://www.ncbi.nlm.nih.gov/pubmed/33725836 http://dx.doi.org/10.1097/MD.0000000000024824

Ejemplares similares

Extranodal NK/T cell lymphoma and lymphomatoid granulomatosis in a patient with chronic lymphocytic leukaemia: Case report for a new perspective on Richter syndrome
por: Abi-Rafeh, Jad, et al.
Publicado: (2020)

Successful treatment with lenalidomide plus chidamide combination therapy in 3 heavily treated patients with non-Hodgkin lymphoma: Three cases report
por: Hu, Shaoxuan, et al.
Publicado: (2020)

Non-Hodgkin lymphoma of multiple extranodal involvement seen on MRI, FDG PET–CT scans: A case report
por: Wang, Shan, et al.
Publicado: (2017)

Case report: Successful treatment of Chidamide in a refractory/recurrent SPTCL with ARID1A mutation on the basis of CHOP plus auto-HSCT
por: Zhang, Nan, et al.
Publicado: (2023)

Septicemia and pneumonia due to Mycobacterium fortuitum infection in a patient with extronodal NK/T-cell lymphoma, nasal type: A case report
por: Cong, Jia, et al.
Publicado: (2017)

Sintilimab combined with chidamide in the treatment of extranodal nature killer/T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis: Two case reports and literature review
por: Xu, Qing-Yuan, et al.
Publicado: (2022)

An unusual extranodal natural killer/T-cell lymphoma presenting as chronic laryngitis: A case report
por: Cruz, Julio, et al.
Publicado: (2021)

Primary extranodal natural Killer/T-cell lymphoma in a child in the colon: A case report
por: Duan, Yi, et al.
Publicado: (2021)

Sintilimab for relapsed/refractory extranodal NK/T cell lymphoma: a multicenter, single-arm, phase 2 trial (ORIENT-4)
por: Tao, Rong, et al.
Publicado: (2021)

Mosquito Bite-Induced Localized NK/T-Cell Lymphoma Relapsed in a Patient with Complete Remission of Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Kondo, Makoto, et al.
Publicado: (2019)

Gemtuzumab ozogamicin monotherapy prior to stem cell infusion induces sustained remission in a relapsed acute myeloid leukemia patient after allogeneic stem cell transplantation: A case report
por: Sumiyoshi, Ritsu, et al.
Publicado: (2020)

Utility of PET/CT in the Diagnosis and Staging of Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Meta-Analysis
por: Zhou, Xiangxiang, et al.
Publicado: (2014)

Phosphatase and tensin homolog (PTEN) is down-regulated in human NK/T-cell lymphoma and corrects with clinical outcomes
por: Fu, Xiaorui, et al.
Publicado: (2017)

Intermediate dose cytarabine improves survival and relapse-free rate compared with standard-dose cytarabine as post-remission treatment for acute myeloid leukemia: A retrospection study
por: Ye, Li, et al.
Publicado: (2021)

Durable Response to Sintilimab and Chidamide in a Patient With Pegaspargase- and Immunotherapy-Resistant NK/T-Cell Lymphoma: Case Report and Literature Review
por: Yan, Zheng, et al.
Publicado: (2020)

Chylothorax after chimeric antigen receptor T cell therapy for relapsed and refractory diffuse large B-cell lymphoma: A case report
por: Chen, Hsin-Hui, et al.
Publicado: (2023)

Combination of atezolizumab and chidamide to maintain long-term remission in refractory metastatic extranodal natural killer/T-cell lymphoma: A case report
por: Wang, Juan, et al.
Publicado: (2022)

Relapsed/refractory acute promyelocytic leukemia with RARA-LBD region mutation was salvaged by venetoclax: A case report
por: Li, Youli, et al.
Publicado: (2021)

Lymphodepletion chemotherapy revitalizes chimeric antigen receptor T cells contributing to regression of relapsed B-cell lymphoma: A case report
por: Liang, Zuyu, et al.
Publicado: (2020)

Multifocal primary cutaneous extranodal NK/T lymphoma nasal type
por: de Vasconcelos, Pedro, et al.
Publicado: (2016)

Educational Case: Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Jia, Yue, et al.
Publicado: (2019)

Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia
por: Koltan, Sylwia, et al.
Publicado: (2015)

Induced complete remission faster in adult patients with acquired pure red cell aplasia by combining cyclosporine A with corticosteroids
por: Wu, Xuemei, et al.
Publicado: (2019)

Double remission of chronic lymphocytic leukemia and secondary acute myeloid leukemia after venetoclax monotherapy: A case report
por: Wang, Lei, et al.
Publicado: (2021)

Efficacy and safety evaluation of fludarabine-based chemotherapy regimen for patients with non-Hodgkin lymphoma: A meta-analysis
por: Zhang, Xiaoping, et al.
Publicado: (2017)

Chidamide and sintilimab combination in diffuse large B-cell lymphoma progressing after chimeric antigen receptor T therapy
por: Hao, Yuan-Yuan, et al.
Publicado: (2022)

Chimeric antigen receptor-modified T-cell therapy for bone marrow and skin relapse Philadelphia chromosome-like acute lymphoblastic leukemia: A case report
por: Yang, Mianzeng, et al.
Publicado: (2020)

Extranodal NK/T-Cell Lymphoma Occurring Primarily in the Eyes and with Central Nervous System Relapse
por: Wei, Chong, et al.
Publicado: (2021)

Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Shi, Zhuangzhuang, et al.
Publicado: (2021)

Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses
por: Nikolaos, Nikitakis, et al.
Publicado: (2012)

Nasal-type extranodal T-cell/NK lymphoma in association with hemophagocytic syndrome
por: Guedes, Juliana Chaves Ruiz, et al.
Publicado: (2018)

Extranodal NK/T-cell lymphoma, nasal type with extensive cardiopulmonary involvement
por: Marques-Piubelli, Mario L., et al.
Publicado: (2021)

Clinical and otorhinolaryngological aspects of extranodal NK/T cell lymphoma, nasal type()()
por: Miyake, Marcel Menon, et al.
Publicado: (2014)

Prediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [(18)F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography
por: Song, Yoo Sung, et al.
Publicado: (2015)

Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review
por: Chen, Chao, et al.
Publicado: (2021)

A long-term retrospective study on sporadic Burkitt lymphoma in chinese population
por: Yang, Xiaoyun, et al.
Publicado: (2020)

P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL
por: Zhang, L., et al.
Publicado: (2022)

Pegylated liposomal doxorubicin (PLD)-containing regimen as a novel treatment of monomorphic epithelial intestinal T-cell lymphoma (MEITL): A case report and review of literature
por: Chen, Yue, et al.
Publicado: (2022)

Second allogeneic transplantation using umbilical cord blood for a patient with relapsed ALK+ anaplastic large cell lymphoma after allogeneic bone marrow transplantation in the era of ALK inhibitors: A case report
por: Saito, Sumiko, et al.
Publicado: (2021)

Successful treatment of hemophagocytic syndrome in a patient with T cell lymphoma, EBV infection, and bone marrow necrosis: A case report
por: Xu, Lingling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oqsi7lc1lnttcloh7p67n5arjs